What top creators are saying about Galt Pharmaceuticals(GALT)

A pharmaceutical company popular with retail investors.

2 AI-extracted insights from 1 source — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Not enough scored insights about Galt Pharmaceuticals in the last 30 days yet.

Top creators covering Galt Pharmaceuticals (GALT)

The 1 sources with the most insights about Galt Pharmaceuticals on Kazuha.

Latest insights about Galt Pharmaceuticals (GALT)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Wednesday, November 12, 2025

Very Bearish

The speaker is short the stock, as it was mentioned in a list of his current short positions.

Martin Shkreli
11/12/25 +516%
Martin ShkreliYouTube223 days ago

Monday, September 8, 2025

Very Bearish

Viewed as an attractive short target due to its popularity with retail investors, whom the speaker believes will eventually lose money, making it a stock they are 'excited to short it again'.

Discussed alongside Galt Pharmaceuticals (GALT)

Other assets that creators frequently mention in the same content as Galt Pharmaceuticals.

Frequently asked

Which podcasters and creators cover Galt Pharmaceuticals (GALT) the most?

The most active sources covering Galt Pharmaceuticals (GALT) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about Galt Pharmaceuticals (GALT) are on Kazuha?

Kazuha has indexed 2 AI-extracted insights about Galt Pharmaceuticals (GALT) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside Galt Pharmaceuticals (GALT)?

Creators covering Galt Pharmaceuticals (GALT) most frequently also discuss HUMA, MSFT, IFRX, NBIS, AMD. See the "Discussed alongside" section above for full asset pages.